Skip to product information
1 of 1

Elabscience

SKU:E-AB-F1051M-20Tests

AF647 Anti-Human CD62L Antibody[DREG56]

AF647 Anti-Human CD62L Antibody[DREG56]

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
The AF647 Anti-Human CD62L Antibody [DREG56] is a highly specific and reliable tool designed for the detection and analysis of CD62L expression in human samples. This monoclonal antibody, produced through advanced biotechnological methods, exhibits exceptional affinity and selectivity towards CD62L, making it an ideal choice for various research applications.

CD62L, also known as L-selectin, is a cell surface glycoprotein that plays a crucial role in lymphocyte homing and migration. It is primarily expressed on the surface of naive T cells, B cells, and subsets of memory T cells. The AF647 Anti-Human CD62L Antibody [DREG56] enables researchers to investigate the expression and distribution of CD62L in different cell populations, aiding in the understanding of immune responses and cellular interactions.

This antibody is conjugated with AF647, a highly fluorescent dye that emits in the far-red spectrum. This feature allows for easy detection and visualization of CD62L expression using flow cytometry, immunofluorescence, and other fluorescence-based techniques. The AF647 conjugate provides excellent signal-to-noise ratio and minimal background interference, ensuring accurate and reliable results.

The AF647 Anti-Human CD62L Antibody [DREG56] has been extensively validated and optimized for use in various experimental conditions. It exhibits exceptional sensitivity and specificity, enabling researchers to confidently analyze CD62L expression in diverse sample types, including peripheral blood mononuclear cells, lymphoid tissues, and cell lines.

With its superior performance and consistent quality, the AF647 Anti-Human CD62L Antibody [DREG56] is an indispensable tool for immunology and cell biology research. Its application extends to studies involving immune cell trafficking, inflammation, autoimmune diseases, and cancer immunotherapy. Researchers can rely on this antibody to provide accurate and reproducible results, facilitating advancements in the understanding and treatment of various human diseases.
View full details